Ozalin (Midazolam)

Midazolam, the active ingredient in Ozalin, is a benzodiazepine presented as a strength/form for intravenous use. It is used for sedation, anxiolysis, and seizure control in hospital settings. GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Midazolam is a short‑acting benzodiazepine that acts on the central nervous system to provide rapid sedation and seizure control.

- Pre‑operative sedation: facilitates calmness and amnesia before surgery. - Procedural sedation: provides safe, controllable sedation for diagnostic or therapeutic procedures. - Status epilepticus: rapidly terminates ongoing seizures when other measures fail. - Intensive care unit sedation: maintains light sedation for mechanically ventilated patients. - Anxiolysis: reduces acute anxiety in emergency or peri‑operative settings. - Seizure emergencies: offers rapid seizure cessation in acute settings.

Midazolam may produce a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling      ​  ​  ​ - Dizziness - Headache - Nausea - Hypotension - Respiratory depression

Serious or Rare  ​  ​  ​  ​  ​  ​  ​  ​  ​ - Anaphylaxis  ​   ​       ​    ​ - Severe respiratory  ​      ​      ​ -          ​          ​